Peer Influences in Alcohol and Sexual Violence Among Marines Dyads
Public ClinicalTrials.gov record NCT07256275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Examining Peer Influences in Alcohol and Sexual Violence Among Marines Using a Dyadic Multimethod Approach
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this experimental study is to examine the complex and multifaceted influence of peers on alcohol-involved sexual violence perpetration (ASVP) in U.S. Marine Corps (USMC) men. The specific aims are: Aim 1: Use ecological momentary assessment (EMA) to examine event-level effects of one's own alcohol use, peer alcohol use, and injunctive norms on ASVP intentions among dyads of Marine men who drink together (n=160 dyads; 320 total participants). Aim 2: Examine the individual and peer effects on ASVP behavior in an experimental paradigm with a gender x confederate (potential victim) intoxication status design. In-the-moment dyad-peer verbalized encouragement for ASVP ("go cues") will be assessed by qualitatively coding verbalizations during the interaction. Aim 3: Examine modifiable risk factors on ASVP intentions in vivo (Aim 1; EMA) and ASVP behavior in vitro (Aim 2; experiment) settings. Participants will complete: 1) an individual orientation session with informed consent, baseline assessment, and EMA demo; 2) 14 days of EMA completed individually; and 3) a dyadic session to complete an experimental paradigm via videoconferencing. All study procedures will be completed in off-duty time as to not interfere with military duties.
Study identification
- NCT ID
- NCT07256275
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 320 participants
Conditions and interventions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 17, 2026
- Primary completion
- Jun 30, 2030
- Completion
- Aug 30, 2030
- Last update posted
- Mar 18, 2026
2026 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Georgia State University | Atlanta | Georgia | 30303 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07256275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07256275 live on ClinicalTrials.gov.